Literature DB >> 18982531

Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.

W Li1, Y Liu, Y-Q He, J-W Zhang, Y Gao, G-B Ge, H-X Liu, H Huo, H-T Liu, L-M Wang, J Sun, Q Wang, L Yang.   

Abstract

Triptolide, the primary active component of a traditional Chinese medicine Tripterygium wilfordii Hook F, has a wide range of pharmacological activities. In the present study, the metabolism of triptolide by cytochrome P450s was investigated in human and rat liver microsomes. Triptolide was converted to four metabolites (M-1, M-2, M-3, and M-4) in rat liver microsomes and three (M-2, M-3, and M-4) in human liver microsomes. All the products were identified as mono-hydroxylated triptolides by liquid chromatography-mass spectrometry (LC-MS). The studies with chemical selective inhibitors, complementary DNA-expressed human cytochrome P450s, correlation analysis, and enzyme kinetics were also conducted. The results demonstrate that CYP3A4 and CYP2C19 could be involved in the metabolism of triptolide in human liver, and that CYP3A4 was the primary isoform responsible for its hydroxylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982531     DOI: 10.1080/00498250802503359

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  17 in total

1.  Metabolism of novel anti-HIV agent 3-cyanomethyl-4-methyl-DCK by human liver microsomes and recombinant CYP enzymes.

Authors:  Xiao-mei Zhuang; Jing-ting Deng; Hua Li; Wei-li Kong; Jin-xiu Ruan; Lan Xie
Journal:  Acta Pharmacol Sin       Date:  2011-10       Impact factor: 6.150

2.  Influence of Verapamil on Pharmacokinetics of Triptolide in Rats.

Authors:  Yichuan Zhang; Jin Li; Xiaolin Lei; Tianying Zhang; Guangxian Liu; Maohui Yang; Min Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-08       Impact factor: 2.441

3.  Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.

Authors:  Hanhua Zhang; Guangkui Ya; Hongbing Rui
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

4.  CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.

Authors:  Ye Xu; Yi-Fan Zhang; Xiao-Yan Chen; Da-Fang Zhong
Journal:  Acta Pharmacol Sin       Date:  2017-12-28       Impact factor: 6.150

5.  CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.

Authors:  Zhexue Wu; Doohyun Lee; Jeongmin Joo; Jung-Hoon Shin; Wonku Kang; Sangtaek Oh; Do Yup Lee; Su-Jun Lee; Sung Su Yea; Hye Suk Lee; Taeho Lee; Kwang-Hyeon Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

6.  Haspin kinase regulates microtubule-organizing center clustering and stability through Aurora kinase C in mouse oocytes.

Authors:  Ahmed Z Balboula; Alexandra L Nguyen; Amanda S Gentilello; Suzanne M Quartuccio; David Drutovic; Petr Solc; Karen Schindler
Journal:  J Cell Sci       Date:  2016-08-25       Impact factor: 5.285

Review 7.  Applications of HPLC/MS in the analysis of traditional Chinese medicines.

Authors:  Miao Li; Xiao-Fang Hou; Jie Zhang; Si-Cen Wang; Qiang Fu; Lang-Chong He
Journal:  J Pharm Anal       Date:  2012-01-30

8.  Critical Role of Hepatic Cyp450s in the Testis-Specific Toxicity of (5R)-5-Hydroxytriptolide in C57BL/6 Mice.

Authors:  Cunzhi Yu; Yu Li; Mingxia Liu; Man Gao; Chenggang Li; Hong Yan; Chunzhu Li; Lihan Sun; Liying Mo; Chunyong Wu; Xinming Qi; Jin Ren
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

9.  Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.

Authors:  Cong Zhang; Fan Peng; Wei Liu; Jiangling Wan; Chunxi Wan; Huibi Xu; Christopher Waikei Lam; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2014-02-20

10.  Metabolism and Metabolic Inhibition of Xanthotoxol in Human Liver Microsomes.

Authors:  Zhongnv Ma; Xianbao Shi; Gang Zhang; Feng Guo; Lina Shan; Jiqun Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.